Poviztra 0.5mg FlexTouch is used to:

• Manage obesity: It is used with a reduced-calorie diet and increased physical activity for chronic weight management in adults with obesity.

• Manage overweight with weight-related health conditions: It may be prescribed for adults with overweight who have at least one weight-related condition.

• Support cardiovascular risk reduction: Semaglutide is indicated to reduce the risk of major adverse cardiovascular events in eligible adults with established cardiovascular disease and obesity or overweight.

Poviztra 0.5mg FlexTouch contains Semaglutide, which activates GLP-1 receptors involved in appetite and food intake.

It increases feelings of fullness and reduces hunger and food intake. Semaglutide also slows stomach emptying, supporting appetite control as part of a reduced-calorie diet and increased physical activity.

Tell your doctor about all prescription medicines, over-the-counter medicines, vitamins and herbal supplements you take.

• Insulin or sulfonylureas: Using these medicines with Semaglutide may increase the risk of low blood sugar.

• Other GLP-1 medicines or Semaglutide products: Do not combine Poviztra with another Semaglutide-containing medicine or GLP-1 receptor agonist unless prescribed.

• Oral medicines: Semaglutide can delay stomach emptying and may affect the absorption of some medicines taken by mouth.

• Store Poviztra 0.5mg FlexTouch in a refrigerator at 2°C to 8°C.

• Do not freeze it or use it if frozen.

• Keep the pen protected from light.

• Keep it out of the sight and reach of children.

• Follow the product packaging instructions for storage after first use.

Poviztra 0.5mg FlexTouch is injected once a week under the skin of the abdomen, thigh or upper arm.

The 0.5mg strength is generally used after the 0.25mg starting dose. It is usually taken for at least four weeks before the dose is increased further, depending on your doctor's advice and how well you tolerate treatment.

Use the FlexTouch pen only after receiving proper instruction on the injection technique. Use a new needle for every injection and never share the pen.

If you miss a dose, follow the missed-dose instructions supplied with your product and prescription. Do not take two doses together.

Common side effects:

• Nausea

• Vomiting

• Diarrhoea

• Constipation

• Abdominal pain

• Headache

• Dizziness

• Indigestion

• Decreased appetite

Serious side effects:

• Severe or persistent abdominal pain

• Severe allergic reactions

• Persistent vomiting or diarrhoea with dehydration

• Gallstones or gallbladder inflammation

• Sudden or worsening changes in vision

• Low blood sugar when used with insulin or sulfonylureas

Seek medical attention if severe or persistent symptoms occur.

• Follow the dose-escalation schedule prescribed by your doctor.

• Do not increase the dose yourself.

• Drink enough fluids, especially if vomiting or diarrhoea occurs.

• Rotate your injection sites regularly.

• Use a new needle for every injection.

• Never share your FlexTouch pen with another person.

• Tell your doctor before surgery or deep sedation.

• Report severe abdominal pain or new vision changes promptly.